Linked inTwitter

Halcyon actively monitors change covering more than 150 key elements of life.

A Mundane Comedy is Dominic Kelleher's new book, which will be published later in 2023. The introduction is available here and further extracts will appear on this site in the coming months. Please get in touch with any questions or thoughts.

The 52:52:52 project, launching both on this site and on Twitter in early 2023 will help you address 52 issues with 52 responses over 52 weeks.

What's Changing? - Alternative



Please see below selected recent alternative lifestyle-related change.


See also:


March 2023

  • The clinical evidence for using psychedelics to treat major mental health conditions is building, but despite the growing data, we don't know just how psychedelics might be helping. One theory behind conditions like depression is that they’re caused by the breakdown of connections between brain cells. Researchers have found, in multiple studies, that psychedelics can increase connections between cortical neurons - specifically, they spark growth of the tendril-y antennae on neurons, called dendrites, that catch signals from other brain cells. In theory, this may mean new connections being formed and strengthened, helping the brain to rewire itself.


December 2022


August 2022

  • The FT noted that, in recent years, microdosing psychedelics has become more mainstream, and some business leaders and HR professionals are evangelising ketamine-assisted therapy as an increasingly popular health benefit for employees. Ketamine is legal for medical use in the US and UK, and while it’s most widely used as an anaesthetic, studies have found ketamine is useful in treating depression and other mental illness. As rates of mental illness increased by more than 25% in the first year of the pandemic, according to a recent report by the World Health Organisation, ketamine-assisted therapy gained popularity as a mental health treatment.


June 2022


October 2021


September 2021


July 2021


May 2021


October 2020

  • Synthesis is an Amsterdam-based wellness retreat claiming to offer the world’s first commercial psychedelic depression therapy. The treatment is medically supervised by  a leading clinical psychologist at Imperial College London’s Centre for Psychedelic Research, who uses psilocybin-infused truffles, which are related to magic mushrooms and legal in the Netherlands. Patients enter a 13-month course that includes monthly group therapy and a five-day retreat with two psilocybin sessions. Since the release of a groundbreaking study in 2016, more and more scientific research points at the medicinal and therapeutic benefits that psychedelic mushrooms can have on patients suffering from depression and other mental illnesses. A commonly cited reason for why psilocybin, the main psychoactive component of magic mushrooms, can be so effective is that it can ‘unshackle’ patients’ minds - enabling them to see things in a different way, consequently leading to lasting shifts in their mindsets.


December 2018


October 2018


September 2018


August 2018